Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

Taking into account the latest results, the current consensus from CVS Health's 23 analysts is for revenues of US$385.9b in ...

Oak Street Health, a wholly-owned subsidiary of CVS Health since 2023, has agreed to pay $60 million to resolve allegations that it violated the False Claims Act (FCA) by paying kickbacks to third ...

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

CVS Health will report earnings on Wednesday morning, weeks after dumping its CEO in a desperate effort to reassure investors ...

CVS Health (NYSE:CVS) is scheduled to announce Q3 earnings results on Wednesday, November 6th, before market open. Analysts ...

CVS Health CEO David Joyner promoted an internal executive, Prem Shah, as company group president and hired from the outside, Steve Nelson, a former UnitedHealthcare CEO.

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...

Among the gains in the contract are the elimination of two-tier wage scale and an increased health care bonus.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...